Accès ouvert
2025
preprint
OpenAlex
Alejandro Allo Anido, Cecilia Roux, Emilia Chen, Siân Hamer et autres
How drug-tolerant persister (DTP) cells escape quiescence to drive tumour relapse is a central unresolved question in cancer evolution. Here, we identify transcriptional noise (TN), defined as the stochastic variability in gene expression, as a latent property of paediatric cancer cells that …
ca, fr, gb
(code pays fourni par la source)
2024
conference-abstract
OpenAlex
Jaydutt Digambar Bhalshankar, Angela Bellini, Irène Jiménez, Cécile Thirant et autres
Abstract Background: In neuroblastoma (NB), intratumor heterogeneity (ITH) is frequently observed, but the role of cell-to-cell allele-specific copy number alterations in phenotypic variation, clonal evolution and treatment response remains to be determined. Here we investigate ITH, timing of specific genomic aberrations, single-cell …
fr, es
(code pays fourni par la source)
Accès ouvert
2024
other
OpenAlex
Charles Bobin, Yasmine Iddir, Charlotte Butterworth, Julien Masliah‐Planchon et autres
AbstractPurpose: The study of cell-free DNA (cfDNA) enables sequential analysis of tumor cell–specific genetic alterations in patients with neuroblastoma. Experimental Design: Eighteen patients with relapsing neuroblastoma having received lorlatinib, a third-generation ALK inhibitor, were identified (SACHA national registry and/or in the institution). …
Accès ouvert
2024
supplementary-materials
OpenAlex
Charles Bobin, Yasmine Iddir, Charlotte Butterworth, Julien Masliah‐Planchon et autres
Supplementary Table Legend
Accès ouvert
2024
other
OpenAlex
Charles Bobin, Yasmine Iddir, Charlotte Butterworth, Julien Masliah‐Planchon et autres
SupplemetaryFigure12345
Accès ouvert
2024
supplementary-materials
OpenAlex
Charles Bobin, Yasmine Iddir, Charlotte Butterworth, Julien Masliah‐Planchon et autres
Supplementary Table 2
Accès ouvert
2024
other
OpenAlex
Charles Bobin, Yasmine Iddir, Charlotte Butterworth, Julien Masliah‐Planchon et autres
AbstractPurpose: The study of cell-free DNA (cfDNA) enables sequential analysis of tumor cell–specific genetic alterations in patients with neuroblastoma. Experimental Design: Eighteen patients with relapsing neuroblastoma having received lorlatinib, a third-generation ALK inhibitor, were identified (SACHA national registry and/or in the institution). …
Accès ouvert
2024
supplementary-materials
OpenAlex
Charles Bobin, Yasmine Iddir, Charlotte Butterworth, Julien Masliah‐Planchon et autres
Supplementary Table 4
Accès ouvert
2024
supplementary-materials
OpenAlex
Charles Bobin, Yasmine Iddir, Charlotte Butterworth, Julien Masliah‐Planchon et autres
Supplementary Table 3
Accès ouvert
2024
supplementary-materials
OpenAlex
Charles Bobin, Yasmine Iddir, Charlotte Butterworth, Julien Masliah‐Planchon et autres
Supplementary Table 1
Accès ouvert
2024
supplementary-materials
OpenAlex
Charles Bobin, Yasmine Iddir, Charlotte Butterworth, Julien Masliah‐Planchon et autres
Supplementary Table 2
Accès ouvert
2024
supplementary-materials
OpenAlex
Charles Bobin, Yasmine Iddir, Charlotte Butterworth, Julien Masliah‐Planchon et autres
Supplementary Table Legend